Themis MedicareBOM:530199 -3.94%70 Gross Margin % is 68.97% as of Mar. 2026, which is 6% above its 10-year median of 64.88. GuruFocus rates BOM:530199 with a GF Score™ of 70/100 and a GF Value™ of ₹149.03 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 938 Drug Manufacturers companies, Themis Medicare ranks better than 71.96% on this metric.
The historical rank and industry rank for Themis Medicare's Gross Margin % or its related term are showing as below:
BOM:530199'
s Gross Margin % Range Over the Past 10 Years
Min: 61.16 Med: 64.88 Max: 67.64
Current: 62.17
During the past 13 years, the highestGross Margin % of Themis Medicare was 67.64%. The lowest was 61.16%. And the median was 64.88%.
BOM:530199's Gross Margin % is ranked better than 71.96% of 938
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs BOM:530199: 62.17
Themis Medicare had a gross margin of 68.97% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Themis Medicare was 0.10% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Themis Medicare had a gross margin of 68.97% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Themis Medicare Gross Margin % Related Terms
Themis Medicare Gross Margin % Historical Data
* Premium members only.
The historical data trend for Themis Medicare's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:530199 vs ZTS, UTHR: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Themis Medicare's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Themis Medicare Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Themis Medicare's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Themis Medicare's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Themis Medicare (BOM:530199) has a Gross Margin % of 68.97% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Themis Medicare and its competitors. This is near median its historical median of 64.88. Over the past decade, Themis Medicare's Gross Margin % has ranged from 61.16 to 67.64. According to the industry distribution chart, Themis Medicare ranks #263 out of 938 companies in the Drug Manufacturers industry, placing it in the top 28%.
Is Themis Medicare's Gross Margin % too high?
Themis Medicare's current Gross Margin % of 68.97% is near median its 10-year median of 64.88. Over the past 10 years, this metric has ranged from a low of 61.16 to a high of 67.64. The Drug Manufacturers industry median Gross Margin % is 48.54. Themis Medicare's value of 68.97% is 42.1% above this industry median. Based on the distribution chart, Themis Medicare ranks #263 out of 938 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Themis Medicare has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Themis Medicare's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Themis Medicare ranks #263 out of 938 companies for Gross Margin %. This puts Themis Medicare in the upper half of its industry. The industry median Gross Margin % is 48.54. Themis Medicare's value of 68.97% is 42.1% above this benchmark. Historically, Themis Medicare's own Gross Margin % has ranged from 61.16 to 67.64 over the past decade. While the company's 10-year median is 64.88 vs. the industry median of 48.54, Themis Medicare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Themis Medicare's current Gross Margin % of 68.97% is 42.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Themis Medicare and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Themis Medicare's current Gross Margin % is 68.97%, which is near median its own 10-year median of 64.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Themis Medicare stock overvalued right now?
Based on GuruFocus' analysis, Themis Medicare (BOM:530199) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹149.03, compared to a current price of ₹112.05 — trading 24.8% below its estimated fair value. The current Gross Margin % is 68.97%, which is near median its 10-year median of 64.88 and 42.1% above the Drug Manufacturers industry median of 48.54. Themis Medicare's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Themis Medicare (BOM:530199), the current Gross Margin % is 68.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Themis Medicare (BOM:530199) Overvalued in 2026?
Based on GuruFocus' analysis, Themis Medicare stock appears to be undervalued.
The current stock price of ₹112.05 is trading 24.8% below its estimated GF Value™ of ₹149.03.
GuruFocus considers Themis Medicare to be Modestly Undervalued.
Key valuation signals for BOM:530199:
Gross Margin %: 68.97% (near median its 10-year median of 64.88)
GF Value™: ₹149.03 vs. price of ₹112.05 (24.8% below fair value)
Industry Position: 42.1% above the Drug Manufacturers median (#263 of 938)
No single metric tells the full story. See the BOM:530199 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Themis Medicare Ltd is an Indian based company engaged in the manufacturing and marketing of pharmaceutical products. The Company operates only in one business segment which is Pharmaceuticals. Geographically, it derives a majority of revenue from India and also has a presence in the international market. Its product categories include Anti Malarial, CCD products, Nutritional Gummies, and Candy and Other Products such as OD-LM, Dexem, Medzol and Tazowin.
70GF Score
Get the complete analysis for BOM:530199
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530199 has been successfully added to your 
